Article Submission 
        Browse Issue by Cover 
   Newsletter 
         JSRM Article Code 
           Subscribe 
        E-Pub 

 

EDITORIAL POLICIES OF JSRM

The Journal of Stem Cells and Regenerative Medicine (JSRM) follows the International Committee of Medical Journal Editors (ICMJE) Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals. For the latest ICMJE recommendation, Click here.

JSRM also endorses the Committee on Publication Ethics (COPE) guidelines.

Manuscripts are considered for publication with an understanding that the manuscript or essential parts of it have not been published previously in any format and is not under consideration by another journal or publication medium.

Authorship:

Authorship should be credited based on all of the four following criteria:

  1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work
  2. Drafting the work or revising it critically for important intellectual content 
  3. Final approval of the version to be published
  4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Those contributors who do not meet all the above four criteria should be acknowledged under the acknowledgement section of the manuscript. It should be understood that all individuals who meet the 1st and/or 2nd criterion should be given the opportunity to meet the rest of the criteria.
It is the collective responsibility of the authors and not JSRM to determine that to name all people who meet all four criteria as authors. In case an agreement cannot be reached, the institution(s) where the work was performed should take the responsibility to name the authors.

In case an author's name has to be removed once the manuscript is accepted for publication and/or if the article is published, a signed statement of agreement for the requested change from all the listed authors of the manuscript and from the author to be removed or added should be sent via email to editor@pubstemcell.com.

If an author changes affiliation before the work is published the current affiliation and contact details should be listed in the acknowledgment section.

Informed consent and ethics:

Patients have a right to privacy that should not be violated without informed consent. Any identifying information should not be published unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. The editor(s) may ask for the signed informed consent forms if required.

When reporting research involving human data, authors should indicate whether the procedures followed were according to the existing local and international guidelines/regulations and if the studies have been assessed by the responsible review committee (institutional and national), or if no formal ethics committee is available, were in accordance with the latest version of the Helsinki Declaration.

When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare (http://veteditors.org/ethicsconsensusguidelines.html).

As per ICMJE recommendations, all clinical trials should be registered in any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp /network/primary/en/index.html) or in ClinicalTrials.gov, which is a data provider to the WHO ICTRP, at or before the time of first patient enrolment as a condition of consideration for publication. The trial number should be mentioned at the end of the abstract and in the Materials and Methods Section of the manuscript. Further all clinical trials should comply with the ICMJE’s clinical trial registration policies (More information available athttp://www.icmje.org/update.html and www.icmje.org /faq_clinical.html) .

Copyright:

Upon submission of any article, the corresponding author will be sent a Copyright transfer form by email. It is the duty of the corresponding author to ensure that that all the authors of the manuscript sign the Copyright transfer form and the scanned copy of the duly signed form must be returned to JSRM by email. Only on receipt of the Copyright transfer form will the manuscript be eligible for publication.

Conflict of Interest:

It is mandatory for each author to disclose all relevant potential financial and other interests that might be influencing the results and contents of the manuscript. On submission, the corresponding author will be sent the Conflict of Interest Declaration form by email and it is the duty of the corresponding author to ensure that that all the authors of the manuscript sign the Conflict of interest declaration form and the scanned copy of the form must be returned to JSRM. Only on receipt of the Conflict of interest Declaration form will the manuscript be eligible for publication.
Please note that several instructions have been adapted and reproduced from the ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals. The ICMJE has not endorsed nor approved the contents of these instructions.

The Peer Review Process:

Authors may submit manuscripts online and they are kept informed about the progress by communication to the corresponding author. Editors manage the whole submission/review/revise/publish process. 

All submitted manuscripts are reviewed and scrutinized initially by the office of the editor.
Manuscripts are evaluated according to the following criteria:

  • Originality of the Material
  • Clarity in Writing
  • Appropriateness of the Language and Style
  • Validity and logic of the Study methods, data and the statistical methods
  • Support of the Conclusion by reasonable data
  • Significance of the information from the readers perspective
  • Compliance of the manuscript with the focus and scope of the journal. 

Manuscripts satisfying the above criteria are sent for formal peer-review to usually three reviewers, but sometimes more in special circumstances. The office of the editor then make a decision based on the reviewers' advice, from among several possibilities:

  • Accept, with or without editorial revisions
  • Accept with Modifications
  • Reject but with indication that authors can re-submit the article after revision
  • Reject outright

Peer reviewer identities and author identities are kept confidential.

The manuscript under review is not revealed to anyone other than peer reviewers and editorial staff. Reviewers, whose names are not disclosed to the authors, will study all contributions, which the editor sends for peer review after considering them to be of sufficient significance and interest.

Normally all articles submitted in full compliance with the guidelines for submission are subjected to an initial scrutiny by the office of editor taking seven working days following which the manuscripts which conform to the guidelines are sent for peer review.

The process of review takes nearly 6-8 weeks before a decision is reached which is then conveyed to the corresponding author.

When a resubmission after revision by the authors is warranted, the office of the editor will interact with the reviewers to arrive at a final decision on the manuscript.

Peer-review guidelines for the reviewers: Click here

Research & Publication misconduct:

In case of suspected or proven research/publication misconduct, if the article has not yet been published, the editorial board will immediately reject the manuscript and may inform third parties such as the author (s)’ institution, ethical committees etc., If already published in JSRM, the article will be retracted following the COPE guidelines.

Retraction/Corrections:

In case of retraction of an article published in JSRM, the original article will be available in the public domain and the details of the retraction will be displayed at appropriate pages in the journal website and the information will be disseminated/indexed in appropriate platforms.
Corrections in a published article, will be published as Erratum, after the consent of the Editorial Board.

Pre-submission enquiries may kindly be directed to webmaster@pubstemcell.com

For providing feedback about the Journal: Click here

To contact us: Click here